2013-10-03 08:34:01 -
Carlsbad, California, October 3, 2013 /Marketwired/ - Aurora Spine Corporation
(TSXV: ASG) announced today it will be exhibiting its product portfolio in
Liverpool, UK at EuroSpine 2013 in booth H51 (Hall 2), from October 2nd until
October 4th. This is the company's first time showcasing at the annual EuroSpine
The company then will participate at the North American Spine Society ("NASS")
tradeshow taking place in New Orleans, LA, USA, October 9th through October
12th. You can visit Aurora Spine at booth 1141.
At this year's meetings, Aurora Spine will present products including the
ZIP(TM) MIS Interspinous Fusion System and Aurora Biologics, giving
glimpse into the Aurora portfolio.
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the
spinal implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.
This news release contains forward-looking information that involves substantial
known and unknown risks and uncertainties, most of which are beyond the control
of Aurora Spine, including, without limitation, those listed under "Risk
Factors" and "Cautionary Statement Regarding Forward-Looking Information"
Aurora Spine's final prospectus (collectively, "forward-looking information").
Forward-looking information in this news release includes information concerning
the growth potential of Aurora Spine's products. Aurora Spine cautions investors
of Aurora Spine's securities about important factors that could cause Aurora
Spine's actual results to differ materially from those projected in any forward-
looking statements included in this news release. Any statements that express,
or involve discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and uncertainties which
could cause actual results or outcomes to differ unilaterally from those
expressed in such forward-looking statements. No assurance can be given that the
expectations set out herein will prove to be correct and, accordingly,
prospective investors should not place undue reliance on these forward looking
statements. These statements speak only as of the date of this press release and
Aurora Spine does not assume any obligation to update or revise them to reflect
new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
President and Chief Executive Officer
Chief Financial Officer
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Aurora Spine Corporation via Thomson Reuters ONE